Vavricka SR - Search Results

1

Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.

Perrig K, Krupka N, Jordi SBU, Rossel JB, Biedermann L, Greuter T, Schreiner P, Vavricka SR, Juillerat P, Burri E, Zimmermann D, Maillard MH, Sulz MC, Brand S, Rogler G, Misselwitz B. Perrig K, et al. Among authors: vavricka sr. Therap Adv Gastroenterol. 2022 Feb 9;15:17562848221074188. doi: 10.1177/17562848221074188. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35154389 Free PMC article.

2

Trichuris trichiura (whipworm).

Vavricka SR, Manz M, Burri E. Vavricka SR, et al. Clin Gastroenterol Hepatol. 2009 Oct;7(10):A16. doi: 10.1016/j.cgh.2008.12.004. Epub 2008 Dec 13. Clin Gastroenterol Hepatol. 2009. PMID: 19264573 No abstract available.

3

Serum protein electrophoresis: an underused but very useful test.

Vavricka SR, Burri E, Beglinger C, Degen L, Manz M. Vavricka SR, et al. Digestion. 2009;79(4):203-10. doi: 10.1159/000212077. Epub 2009 Apr 9. Digestion. 2009. PMID: 19365122 Free article. Review.

4

Treatment of severe ulcerative colitis: differences in elderly patients?

Vavricka SR, Rogler G. Vavricka SR, et al. Dig Dis. 2009;27(3):315-21. doi: 10.1159/000228567. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786758 Free article. Review.

5

New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options?

Vavricka SR, Rogler G. Vavricka SR, et al. Swiss Med Wkly. 2009 Sep 19;139(37-38):527-34. doi: 10.4414/smw.2009.12520. Swiss Med Wkly. 2009. PMID: 19838869 Free article. Review.

6

Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS survey.

Schoepfer AM, Vavricka SR, Binek J, Felley C, Geyer M, Manz M, Rogler G, de Saussure P, Sauter B, Seibold F, Straumann A, Michetti P; Swiss IBDnet. Schoepfer AM, et al. Among authors: vavricka sr. Inflamm Bowel Dis. 2010 Jun;16(6):933-8. doi: 10.1002/ibd.21127. Inflamm Bowel Dis. 2010. PMID: 20014021 Clinical Trial.

7

Clinical experience with adalimumab in a multicenter Swiss cohort of patients with Crohn's disease.

Nichita C, Stelle M, Vavricka S, El-Wafa Ali A, Ballabeni P, de Saussure P, Straumann A, Rogler G, Michetti P. Nichita C, et al. Digestion. 2010;81(2):78-85. doi: 10.1159/000253855. Epub 2010 Jan 12. Digestion. 2010. PMID: 20093835 Free article.

8

Recent advances in the etiology and treatment of Crohn's disease.

Vavricka SR, Rogler G. Vavricka SR, et al. Minerva Gastroenterol Dietol. 2010 Jun;56(2):203-11. Minerva Gastroenterol Dietol. 2010. PMID: 20485257 Review.

9

Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.

Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, Schoepfer AM. Vavricka SR, et al. Am J Gastroenterol. 2011 Jan;106(1):110-9. doi: 10.1038/ajg.2010.343. Epub 2010 Aug 31. Am J Gastroenterol. 2011. PMID: 20808297

10

Dying in yoghurt: the number of living bacteria in probiotic yoghurt decreases under exposure to room temperature.

Scharl M, Geisel S, Vavricka SR, Rogler G. Scharl M, et al. Among authors: vavricka sr. Digestion. 2011;83(1-2):13-7. doi: 10.1159/000308715. Epub 2010 Sep 14. Digestion. 2011. PMID: 20838050 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters